Dr. Rohan Maniar, MD
Claim this profileIndiana University Simon Cancer Center
Studies Solid Tumors
Studies Non-Small Cell Lung Cancer
2 reported clinical trials
3 drugs studied
Area of expertise
1Solid Tumors
Stage IV
EGFR negative
RET negative
2Non-Small Cell Lung Cancer
Stage IV
EGFR negative
RET negative
Affiliated Hospitals
Clinical Trials Rohan Maniar, MD is currently running
SIM0237
for Solid Tumors
This is a multicenter, open-label, phase I study to evaluate the safety, efficacy, and pharmacokinetic (PK)/pharmacodynamic(PD) characteristics of SIM0237 in participants with advanced solid tumors.
Recruiting1 award Phase 1
DSP107 + Atezolizumab
for Solid Tumors
Part 1: A first-in-human, open-label, Phase I dose escalation study of DSP107 monotherapy and combination therapy with atezolizumab in patients with advanced solid tumors. Part 2: Preliminary efficacy assessment of DSP107 in combination with atezolizumab in second or third line treatment of non small cell lung cancer. Preliminary efficacy assessment of DSP107 as a single agent or in combination with atezolizumab in third line treatment of colorectal cancer.
Recruiting1 award Phase 1 & 29 criteria
More about Rohan Maniar, MD
Clinical Trial Related1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Rohan Maniar, MD has experience with
- Atezolizumab
- DSP107
- SIM0237
Breakdown of trials Rohan Maniar, MD has run
Non-Small Cell Lung Cancer
Colorectal Cancer
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rohan Maniar, MD specialize in?
Rohan Maniar, MD focuses on Solid Tumors and Non-Small Cell Lung Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are EGFR negative.
Is Rohan Maniar, MD currently recruiting for clinical trials?
Yes, Rohan Maniar, MD is currently recruiting for 2 clinical trials in Indianapolis Indiana. If you're interested in participating, you should apply.
Are there any treatments that Rohan Maniar, MD has studied deeply?
Yes, Rohan Maniar, MD has studied treatments such as Atezolizumab, DSP107, SIM0237.
What is the best way to schedule an appointment with Rohan Maniar, MD?
Apply for one of the trials that Rohan Maniar, MD is conducting.
What is the office address of Rohan Maniar, MD?
The office of Rohan Maniar, MD is located at: Indiana University Simon Cancer Center, Indianapolis, Indiana 46202 United States. This is the address for their practice at the Indiana University Simon Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.